Jewell Christopher M 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Jewell Christopher M
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-01-02+778,200→ 778,200 total - Award
Employee Stock Option (right to buy)
2024-01-02+998,000→ 998,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (998,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
- [F2]This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.